fri
MAY 11, 2018 / 5:30 pm
Wall Street rises with healthcare rally after Trump's speech
DJ: 24,831.17 +91.64 NAS: 7,402.88 -2.09 S&P: 2,727.72
+4.65 5/11
(Reuters)
- The S&P 500 rose on Friday, helped by healthcare stocks after
President Donald Trump blasted high drug prices but avoided taking aggressive
measures to cut them.
Johnson & Johnson and
Pfizer each rose over 1 percent while Merck & Co jumped 2.8 percent after
Trump in a speech said foreign governments “extort” unreasonably low prices
from U.S. drugmakers. His healthcare deputies released a series of proposals to
address high drug costs.
“They’ve walked the tightrope between cost savings for the
American people and maximizing profits for publicly traded healthcare stocks,”
said Jake Dollarhide, chief executive officer of Longbow Asset Management in
Tulsa, Oklahoma. The S&P healthcare
index ended 1.47 percent higher, while the Nasdaq Biotechnology index rallied
2.68 percent.
The
tech sector slipped 0.32 percent, with Apple Inc dropping 0.38 percent after a
nine-day winning streak
that saw the iPhone maker edge closer to $1 trillion
in market capitalization.
Also weighing on tech was Nvidia, which
fell 2.15 percent on worries that a short-term surge in demand for graphics
chips from cryptocurrency miners may be undermining the
company’s core business with computer gamers.
“Tech is giving
back some of its gains. Market participants are not making aggressive
bets after the week we’ve had, heading into the weekend,” said Keith Lerner,
chief market strategist at SunTrust Advisory Services in Atlanta. “We’re in a
holding pattern today, digesting the strong gains of the week.”
The Dow Jones Industrial
Average rose 91.64 to end at 24,831.17 points, while the S&P 500 gained 4.65
to 2,727.72, its highest close since mid-March. The Nasdaq Composite slipped -2.09
to 7,402.88. For the week, the Dow rose 2.3 percent, the
S&P 500 added 2.4 percent, and the Nasdaq climbed 2.7 percent.
During Friday’s session, the Dow edged above 100-day moving average for the first time
since April 18, following the S&P 500’s similar move a day earlier.
Some traders believe such developments mean the market is likely to move higher.
Volume on U.S. exchanges
was 5.8 billion shares,
light compared with the 6.6 billion-share average over the last 20 trading
days.
With March-quarter reports mostly wrapped up, S&P 500 companies appear to
have grown their earnings per share by 26 percent, according to Thomson
Reuters I/B/E/S. Due to increased
expectations for corporate profits and a dip in stock prices since January, the
S&P 500 is now trading at 16 times expected earnings, its lowest multiple
in two years, according to Thomson Reuters Datastream. “We have very strong fundamentals from an earnings perspective and
valuations are looking a bit more reasonable than they were late last year,”
said Bill Northey, senior vice president at U.S. Bank Wealth Management.
Boosting the Dow was Verizon, which rose 3 percent after JPMorgan
upgraded the wireless carrier to “overweight,” saying 5G opportunity will start
to crystallize in the next few months.
Symantec slumped 33 percent after
the Norton Antivirus maker said it was investigating
concerns raised by a former employee.
Advancing issues outnumbered declining
ones on the NYSE by a 1.24-to-1 ratio; on Nasdaq, a 1.23-to-1 ratio favored
advancers. The S&P 500 posted 30 new
52-week highs and three new lows; the Nasdaq Composite recorded 137 new highs
and 51 new lows.
No comments:
Post a Comment